Uncertainty over the Formation and Terms of Pharmaceutical Out-Licensing and In-Licensing Partnerships

The risk that, based on the assessments and decisions of pharmaceutical companies and other parties, out-licensing or in-licensing agreements for pharmaceuticals, joint research agreements, or partnership agreements may not be concluded, or that the contractual terms may differ from expectations.